The Prostacyclin Analog Beraprost Sodium Ameliorates Characteristics of Metabolic Syndrome in Obese Zucker (Fatty) Rats

por Sato, Nahoko, Kaneko, Masayuki, Tamura, Mitsutaka, Kurumatani, Hajimu
Publicado 2010

Prostacyclin analog beraprost sodium efficacy in primary glomerular disease or nephrosclerosis: Analysis of the Japanese subgroup in CASSIOPEIR study

por Kurumatani, Hajimu, Okada, Kiyonobu, Origasa, Hideki, Fujita, Toshiro, Isono, Masanao, Nakamoto, Hidetomo
Publicado 2021

A multinational phase IIb/III trial of beraprost sodium, an orally active prostacyclin analogue, in patients with primary glomerular disease or nephrosclerosis (CASSIOPEIR trial),...

por Nakamoto, Hidetomo, Fujita, Toshiro, Origasa, Hideki, Isono, Masanao, Kurumatani, Hajimu, Okada, Kiyonobu, Kanoh, Hiroyuki, Kiriyama, Takashi, Yamada, Shunsuke
Publicado 2014

Orally active prostacyclin analogue beraprost sodium in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled, phase II dose finding trial

por Koyama, Akio, Fujita, Toshiro, Gejyo, Fumitake, Origasa, Hideki, Isono, Masanao, Kurumatani, Hajimu, Okada, Kiyonobu, Kanoh, Hiroyuki, Kiriyama, Takashi, Yamada, Shunsuke
Publicado 2015